Short Interest in ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Rises By 94.3%

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 68,200 shares, a growth of 94.3% from the May 31st total of 35,100 shares. Currently, 1.9% of the shares of the company are short sold. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

ThermoGenesis Stock Down 9.1 %

THMO stock traded down $0.02 during trading hours on Friday, hitting $0.20. 11,163 shares of the stock were exchanged, compared to its average volume of 88,616. ThermoGenesis has a 12 month low of $0.20 and a 12 month high of $1.82. The company has a 50-day simple moving average of $0.56 and a two-hundred day simple moving average of $0.65.

ThermoGenesis (NASDAQ:THMO) last issued its quarterly earnings results on Monday, April 15th. The company reported ($2.33) EPS for the quarter. ThermoGenesis had a negative return on equity of 4,838.39% and a negative net margin of 153.43%. The company had revenue of $2.41 million during the quarter. On average, equities analysts anticipate that ThermoGenesis will post 0.08 earnings per share for the current year.

ThermoGenesis Company Profile

ThermoGenesis Holdings, Inc develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.